• Home
  • Licensing
  • Browse All

All Available Technologies

Currently there are no good treatment options for individuals diagnosed with pancreatic cancer. As a result, the two year survival rate after diagnosis is only 10%. Thus, novel therapeutic agents are needed that effectively treat pancreatic cancer.
 
The current invention is novel crocetinic analogs that have showed reduced proliferation of pancreatic cancer cells and inhibited metastasis in pancreatic cancer mouse model. These analogs carry out this function by targeting key factors that function in pancreatic cancer tumor growth. The analogs are stable and non-toxic.
Category(s):

KU research has identified combinations of surfactants and polyelectrolyte nanoparticles that improve the stability of CO2 foam for enhanced oil recovery (EOR).

Category(s):
Subcategory(s):

A novel hair growth-enhancing formulation for the treatment of male pattern baldness (androgenic alopecia).

Category(s):
Subcategory(s):

The current invention is a novel class of compounds that function as KOR antagonists.  Because KOR activation has been linked to depression and anxiety related disorders, this novel class of compounds may be used in the development of therapies to treat these mental disorders

Category(s):

This invention consists of a novel composition of matter as well as a process for the efficient conversion of glycerol to lactic acid.

Subcategory(s):

LED traffic signal system which melts snow and ice, preventing loss of visibility.

Subcategory(s):
A space- and water-efficient fume hood heat exchanger system that utilizes a chilled water supply to cool laboratory equipment, reducing a lab’s operational costs and risk of flooding.
 
Read our blog on Efficient Heat Exchange Systems for Sustainable Labs.
Category(s):
Subcategory(s):

The invention offers novel composition of matter to be used in treatment of a number of hormone responsive cancers.

Category(s):

Small molecule adjuvants that act as vaccine adjuvants by specifically binding to Toll-Like Receptor-8 (TLR8).

Category(s):
Subcategory(s):

A three-dimensional tumor-in-dish (TID) cell-based assay kit for cancer drug screening that closely replicates actual cellular microenvironments and, therefore, can determine which compounds to move forward for in vivo testing. 

Subcategory(s):

Pages


Events
KU Today